Publikationer

Dansk Lunge Cancer Register har leveret data til eller bidraget til følgende publikationer:

  1. Jakobsen E, Palshof T. et al.: Data from a national lung cancer registry contributes to improve outcome an quality of surgery: Danish results. Car.thor. sur. 2009, 35 (2): 348-52
  2. Wildgaard K, Ravn J, et al.: Consequences of persistent pain after lung cancer surgery: a nationwide questionnaire study. Acta Anaesthesiol Scan 2011 55:60-68
  3. Dalton SO, Frederiksen BL et al.: Socioeconomic position, stage of lung cancer and time between referral and diagnosis in Denmark, 2001-2008 BJC (2011) 105, 1042-1048
  4. Lipczak H., Neckelmann K. et al.: Uncertain added value of global Trigger Tool for monitoring of patient safety in cancer care. Dan Med Bul 58/11
  5. Lüchtenborg M. et al: The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients. European Journal of Cancer 2012;48(18):3386-95
  6. Jakobsen E. et al: Dansk Lunge Cancer Register. Ugeskr Læger 174/42, 2012; 2539
  7. Starr L. et al.: Socioeconomic position and surgery for early-stage non small cell lung cancer: a population-based study in Denmark. Lung Cancer 79 (2013) 262– 269
  8. Walters S. et al: Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom: a population-based study, 2004- 2007. Thorax 2013;0:1–14
  9. Licht P.B. et al: A National Study of Nodal Upstaging After Thoracoscopic Versus Open Lobectomy for Clinical Stage-1 Lung Cancer. Afp. in Annals of Thorcic Surgery
  10. Jakobsen E. et al: Nationwide quality improvement in lung cancer care: The Danish Lung Cancer Registry. in Journal of Thoracic Oncology
  11. Lüchtenborg M. et al: High procedure volume is strongly associated with improved survival after lung cancer surgery. Afp. in Journal of Clinical Oncology
  12. Ledderer L. et al: Feasibility of a psychosocial rehabilitation intervention to enhance the involvement of relatives in cancer rehabilitation. Pilot study for a randomized controlled trial. Sfp. in The Patient: Patient–Centered Outcomes Research
  13. Lüchtenborg M. et al: Survival of small cell lung cancer patients undergoing lung resection in England 1998- 2009. BMJ  2013
  14. Søgaard R., Fischer BM., Mortensen J., Rasmussen TR., Lassen U.: The Optimality of Different Strategies for Supplemental Staging of Non–Small-Cell Lung Cancer: A Health Economic Decision Analysis. Value in Health 16 (2013): 57-65
  15. Lüchtenborg M., Jakobsen E., Peake M.D., Møller H.: Mortality after surgery for Small Cell Lung Cancer. Thorax 2013;0:1–5
  16. Jakobsen E., Green A.: DMCG.dk Benchmarking Consortium: Lungekræft 2000 – 2012 
  17. Iachina M., Green A., Jakobsen E. et al.: The direct and indirect impact of comorbidity on the survival of patients with non-small cell lung cancer: a combination of survival, staging and resection models with missing measurements in covariates. BMJ Open 2014;4:e003846
  18. Blum T., Jakobsen E. et al: ERS task force report: The European Initiative for Quality Management in Lung Cancer Care. The European Respiratory Journal 2014/03
  19. Licht P., Schytte T., Jakobsen E.: Adjuvant Chemotherapy Compliance  Is Not superior After Thoracoscopic Lobectomy. Ann Thorac Surg. 2014 Aug;98(2):411-5; discussion 415-6
  20. Skov B.G, Høgdal E. et al.: The prevalence of EGFR mutations in non-small cell lung cancer in an unseleted Caucasian population APMS 123: 108-116
  21. Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, Goldstraw P; International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members and Participating Institutions.: The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2014 Nov;9(11):1618-24
  22. Mellemgaard A., Lüchtenborg M. et al: Role of comorbidity on survival after radio- and chemotherapy for non-surgically treated lung cancer. J Thorac Oncol. 2015 Feb;10(2):272-9
  23. Iachina M., Jakobsen E. et al: The Effect of Different Comorbidities on Survival of Non-small Cells Lung Cancer Patients. Lung 2015 193:291–297
  24. Laursen LØ, Petersen RH et al: Video-assisted thoracoscopic surgery lobectomy for lung cancer is associated with a lower 30-day morbidity compared with lobectomy by thoracotomy. Eur J Cardiothoracic Surg (2015); 49(3):870-5
  25. Dalton S, Steding-Jessen M et al.: Socioeconomic position and survival after lung cancer – the influence of stage, treatment and comorbidity among Danish lung cancer patients diagnosed 2004-2010. Acta Oncol.2015 May;54(5):797-804
  26. Green A., Hauge J. et al: The mortality after surgery in primary lung cancer: results from the Danish Lung Cancer Registry. European Journal of Cardio-Thoracic Surgery (2015); 49(2): 589-94
  27. Jakobsen E., Rasmussen T.R.: The Danish Lung Cancer Registry. Clinical Epidemiology (2016) publicated online
  28. Jakobsen E., Riis Rasmussen T. et al: Mortality and survival of Lung Cancer in Denmark: Results from the Danish Lung Cancer Group 2002-2012. Acta Oncologica (2016) 1-8
  29. O´Dowd EL, Lüchteenborg M et al: Predicting death from surgery for lung cancer. A comparison of two scoring systems in two European countries. Lung Cancer (2016)95, 88-93
  30. Møller H., Riaz SP et al: High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of readmission and death: national cohort analysis in England. Accepted for publication in European Journal of Cancer
  31. Jakobsen E., Rasmussen T.R.: The Danish Lung Cancer Registry. Clinical Epidemiology 2016:8 537-541
  32. Møller H., Jakobsen E et al: High lung cancer surgical procedure volume is associated with shorter length of stay and lower risks of readmission and death: national cohort analysis in England. Eur J Cancer. 2016 Sep;64:32-43
  33. Guldbrandt LM, Møller H, et al: General practice consultations, diagnostic investigations and prescriptions in the year preceding a lung cancer diagnosis. Cancer Medicine 2017; 6(1):79–88
  34. Eckardt J, Jakobsen E, et al: Subcarinal Lymph Node Schould be Dissection in All Lobectomies for Non-Small Cell Lung Cancer – Regardless of Primary Tumor Location Ann Thorac Surg 2017;103:1121–5
  35. Iachina M., Brønserud MM, et al.: History of Depression in Lung Cancer Patients: Impact of delay. Clinical Oncology 2017 Sep;29(9):585-592
  36. Iachina M, Green A, et al.: Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study. BMC Health Services Research 2017 Apr 12;17(1):267
  37. Rich A., Baldwin D, et al.: Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries, BMC Cancer (2019) 18:114
  38. Jeppesen SS, Hansen NCG et al.: Survival of localized NSCLC patients without active treatment or treated with SBRT. Acta Oncologica 2018 Feb;57(2):219-225
  39. Rich A.L, Baldwin D.R, et al.: ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe. European Respiratory Journal 2018
  40. Møller, H, Goupland V.H, et al.: Geographical variations in the use og cancer treatments are associated with survival of lung cancer patients. Thorax 2018;0:1-8 
  41. Christensen N.L, Kejs A.M.T. et al.: Early death in Danish stage I lung cancer patients: a population-based case study. Acta Oncologica 2018 vol. 57:1561-1566
  42. Brønserud M.M, Iachina M, et al.: Patient-reported outcomes (PROs) in lung cancer: Excperiences from a nationwide feasibility study. Lung Cancer 128 (2019) 67-73
  43. Brønserud M.M, Iachina M, et al.: Patient reported outcome data as performance indicators in surgically treated lung cancer patients. Lung Cancer 130 (2019) 143-148
  44. Christensen N.L, Dalton S, et al.: Treatment, no treatment and early death in Danish stage I lung cancer patients. Lung Cancer 131 (2019) 1-5